Procurement Summary
Country: Brazil
Summary: The Object of the Bidding is the Price Registration for Future and Eventual Acquisitions of Medicines, under the Conditions Established in this Notice and its Annexes.
Deadline: 08 Jun 2026
Posting Date: 22 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141848296
Document Ref. No.: 90598/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - The object of the bidding is the Price Registration for future and eventual acquisitions of medicines, under the conditions established in this notice and its annexes. UASG code: 943001 Notice from: 05/25/2026 from 08:00 to 12:00 pm and from 2:00 pm to 5:59 pm Proposal Delivery: from 05/25/2026 at 08:00 CLOBETASOL, ACTIVE INGREDIENT PROPIONATE SALT, CONCENTRATION 0.05%, CREAM PRESENTATION Quantity: 23400 DEXAMETHASONE, DOSAGE 0.1%, CREAM PRESENTATION Quantity: 908800 DICLOFENAC, COMPOSITION DIETHYLAMONIUM SALT, CONCENTRATION 20 MG/G, PHARMACEUTICAL GEL FORM Quantity: 3350 SODIUM GLYCEROPHOSPHATE, CONCENTRATION 216 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 3500 GLUCOSAMIN, COMPOSITION ASSOCIATED WITH CHONDROITIN, IN SALTS SULFATES, CONCENTRATION 1.5 G + 1.2 G, PHARMACEUTICAL FORM ORAL POWDER Quantity: 1601040 HEPARIN SODIUM, CONCENTRATION 200 IU/G, PHARMACEUTICAL GEL FORM Quantity: 3400 METHYLPREDNISOLONE, ACTIVE INGREDIENT SUCCINATE SALT, DOSAGE 500 MG, PRESENTATIONLYOPHILIZED POWDER + DILUENT, INJECTABLE Quantity: 13500 PAPAVERINE, DOSAGE 50 MG/ML, INJECTABLE INDICATION Quantity: 1400 POLYSTYRENESULFONATE, CALCIUM COMPOSITION, CONCENTRATION 900 MG/G, PHARMACEUTICAL FORM POWDER FOR ORAL SUSPENSION Quantity: 6860 SALTS FOR REHYDRATION ORAL, COMPOSITION SODIUM, POTASSIUM, CHLORIDE, CITRATE AND GLUCOSE, CONCENTRATION 45 MEQ/L + 20 MEQ/L + 35 MEQ/L + 30 MEQ/L + 126 MMOL/L, PHARMACEUTICAL FORM ORAL SOLUTION Quantity: 1273160
Documents
Tender Notice